Droxinostat

Catalog No. :
ACQWZL513
CAS No. :
99873-43-5
Molecular Formula :
C11H14ClNO3
Molecular Weight :
243.69

IUPAC Name:4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide

Droxinostat structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10mg99%$54.00Login to see priceIn stockInquiry
50mg99%$116.00Login to see priceIn stockInquiry
100mg99%$139.00Login to see priceIn stockIn stock
250mg99%$231.00Login to see priceIn stockIn stock
1g99%$600.00Login to see priceIn stockIn stock
5g99%$2910.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameDroxinostat
IUPAC Name4-(4-chloro-2-methylphenoxy)-N-hydroxybutanamide
MDL No.MFCD01326592
Molecular FormulaC11H14ClNO3
Molecular Weight243.69
SMILESClC1=CC=C(C(C)=C1)OCCCC(NO)=O
InChI KeyJHSXDAWGLCZYSM-UHFFFAOYSA-N
Synonym4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide | BCP9000629 | SR-01000220670 | 4-(4-chloro-2-methyl-phenoxy)butanehydroxamic acid | CBChromo1_000102 | AG-669/02914008 | SR-01000220670-1 | A916248 | MLS006011918 | F0890-0044 | NCGC00087387-11 | 9-Cyclope
CAS No.99873-43-5
PubChem CID568416

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACQWZL513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQWZL513 route product structure diagram
    ACQWZL51399873-43-5 In Stock
Inquiry

2. ACQWZL513 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACQWZL513 route product structure diagram
    ACQWZL51399873-43-5 In Stock
Inquiry

Comments (0)